Glucagon usually raises blood sugar (it's the signal your liver sends when glucose is low), but in this context, stimulating the glucagon receptor appears to increase energy expenditure and accelerate fat burning, particularly from the liver
Our commitment to excellence extends across our entire catalog, from metabolic research compounds to nootropics like Dihexa and cell-regenerating peptides
The two drugs may share a pharmacological category, but their safety profiles are not equivalent
Injectables require refrigeration, which may be challenging for patients without stable housing, privacy, or climate control
Receptors are typically protein-based and embedded in cell membranes
Severe, persistent or worsening side effects should not be ignored